Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)

Abstract Background Despite the common use of topical ophthalmic corticosteroids in dogs, detailed reports on systemic and dermatologic adverse effects are limited. Results Nine purpose-bred research Beagles were treated with difluprednate 0.05% ophthalmic emulsion in one or both eyes 2–3 times dail...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katelin Quantz, Amanda L. Anderson, Christine D. Harman, Erica L. Noland, Jacquelyn M. Del Valle, Laurence M. Occelli, Jessica B. Burn, Simon M. Petersen-Jones, Daniel K. Langlois, Chris G. Pirie, Annette D. Petersen, András M. Komáromy
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/3ef3d59deba34f8196436fe5f73b6480
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!